Richard T. Williams

10.0k citations

60 papers · 4.6k indexed · 1 hit paper · h-index 31

Molecular Biology top 5%
Oncology top 1%
Cancer Research top 1%
Pulmonary and Respiratory Medicine top 5%
Pathology and Forensic Medicine top 2%

Co-authors: Charles J. Sherr Kelly S. Oliner Isaac Kinde Johannes G. Reiter Martin A. Nowak Kenneth W. Kinzler Luis A. Díaz Benjamin Allen
Topics: Chronic Myeloid Leukemia Treatments (13 papers)Cancer Genomics and Diagnostics (9 papers)Cancer-related Molecular Pathways (9 papers)
Cited by: Sensory Systems Cancer Research Oncology
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Australia United Kingdom

In The Last Decade

Richard T. Williams

58 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

2012 1.3k citations Luis A. Díaz, Richard T. Williams et al. Nature profile →

Peers

Countries citing papers authored by Richard T. Williams

Since Specialization

Citations

This map shows the geographic impact of Richard T. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard T. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard T. Williams more than expected).

Fields of papers citing papers by Richard T. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard T. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard T. Williams. The network helps show where Richard T. Williams may publish in the future.

Co-authorship network of co-authors of Richard T. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Richard T. Williams. A scholar is included among the top collaborators of Richard T. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard T. Williams. Richard T. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Altered toxicological endpoints in humans from common quaternary ammonium compound disinfectant exposure 2021 ·Toxicology Reports ·Terry C. Hrubec,Ryan P. Seguin,Libin Xu,Gino Cortopassi,Sandipan Datta,Alexandra L. Hanlon,Alicia Lozano,(unknown),(unknown),(unknown),(unknown),Richard T. Williams	89
2	Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia 2020 ·Clinical Lymphoma Myeloma & Leukemia ·Farhad Ravandi,Sherry Pierce,Guillermo Garcia‐Manero,Tapan M. Kadia,Elias Jabbour,Gautam Borthakur,Courtney D. DiNardo,Naval Daver,Nicholas J. Short,Yesid Alvarado,Jörge E. Cortes,Christopher Kim,Michael A. Kelsh,Aaron J. Katz,Richard T. Williams,Zhao Yang,Bhakti Mehta,Hagop M. Kantarjian	11
3	Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia 2015 ·PLoS ONE ·Laura B. Ramsey,Laura J. Janke,(unknown),Xiangjun Cai,Steven W. Paugh,Seth E. Karol,Landry K. Kamdem,Cheng Cheng,Richard T. Williams,Sima Jeha,Ching‐Hon Pui,William E. Evans,Mary V. Relling	11
4	High Expression of CAI2 , a 9p21 -Embedded Long Noncoding RNA, Contributes to Advanced-Stage Neuroblastoma 2014 ·Cancer Research ·Lisa M. Barnhill,Richard T. Williams,(unknown),(unknown),Ayse Batova,(unknown),Karen Messer,Minya Pu,Lei Bao,Alice L. Yu,Mitchell B. Diccianni	39
5	Evaluation of KRAS, NRAS, and BRAF Mutations in Prime: Panitumumab with FOLFOX4 as First-Line Treatment in Metastatic Colorectal Cancer (MCRC) 2013 ·Annals of Oncology ·Kelly S. Oliner,Jean‐Yves Douillard,Salvatore Siena,Josep Tabernero,Ronald L. Burkes,Mario Barugel,Yves Humblet,G. Bodoky,David Cunningham,Jacek Jassem,Fernando Rivera,Ilona Kocáková,Paul Ruff,(unknown),Martin Šmakal,Richard T. Williams,Alan Rong,Jeffrey S. Wiezorek,Roger Sidhu,Scott D. Patterson	2
6	A Screening-Based Approach to Circumvent Tumor Microenvironment-Driven Intrinsic Resistance to BCR-ABL+ Inhibitors in Ph+ Acute Lymphoblastic Leukemia 2013 ·SLAS DISCOVERY ·Harpreet Singh,Anang A. Shelat,Amandeep Singh,Nidal Boulos,Richard T. Williams,R. Kiplin Guy	10
7	The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersbreakdown → 2012 ·Nature ·Luis A. Díaz,Richard T. Williams,Jian Wu,Isaac Kinde,J. Randolph Hecht,Jordan Berlin,Benjamin Allen,Ivana Božić,Johannes G. Reiter,Martin A. Nowak,Kenneth W. Kinzler,Kelly S. Oliner,Bert Vogelstein	1290
8	A mammalian functional-genetic approach to characterizing cancer therapeutics 2010 ·Nature Chemical Biology ·Hai Jiang,Justin R. Pritchard,Richard T. Williams,Douglas A. Lauffenburger,Michael T. Hemann	2
9	Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl 2010 ·Cancer Cell ·Mark A. Gregory,Tzu Phang,Paolo Neviani,Francesca Alvarez‐Calderon,Christopher A. Eide,Thomas O’Hare,Vadym Zaberezhnyy,Richard T. Williams,Brian Druker,Danilo Perrotti,James DeGregori	141
10	The INK4-ARF (CDKN2A/B) Locus in Hematopoiesis and BCR-ABL-induced Leukemias 2008 ·Cold Spring Harbor Symposia on Quantitative Biology ·Richard T. Williams,Charles J. Sherr	53
11	Failure of CDKN2A/B (INK4A/B–ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL 2008 ·Genes & Development ·Charles G. Mullighan,Richard T. Williams,James R. Downing,Charles J. Sherr	68
12	Cytokine-dependent imatinib resistance in mouse BCR-ABL⁺, Arf-null lymphoblastic leukemia 2007 ·Genes & Development ·Richard T. Williams,Willem den Besten,Charles J. Sherr	134
13	The Arf Tumor Suppressor in Acute Leukemias: Insights from Mouse Models of Bcr–Abl-Induced Acute Lymphoblastic Leukemia 2007 ·Advances in experimental medicine and biology ·Richard T. Williams,Charles J. Sherr	12
14	Myeloid Leukemia-Associated Nucleophosmin Mutants Perturb p53-Dependent and Independent Activities of the Arf Tumor Suppressor Protein 2005 ·Cell Cycle ·Willem den Besten,Mei-Ling Kuo,Richard T. Williams,Charles J. Sherr	85
15	p53-Dependent and -Independent Functions of the Arf Tumor Suppressor 2005 ·Cold Spring Harbor Symposia on Quantitative Biology ·Charles J. Sherr,David Bertwistle,Willem den Besten,(unknown),Masataka Sugimoto,Kenji Tago,Richard T. Williams,Frédérique Zindy,Martine F. Roussel	84
16	Stromal interaction molecule 1 (STIM1), a transmembrane protein with growth suppressor activity, contains an extracellular SAM domain modified by N-linked glycosylation 2002 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Richard T. Williams,P. V. Senior,(unknown),Judith E. Layton,Peter J. Smith,Marie Dziadek	124
17	Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins 2001 ·Biochemical Journal ·Richard T. Williams,Shehnaaz S.M. Manji,Nigel J. Parker,(unknown),(unknown),(unknown),P. V. Senior,Jan Kazenwadel,Tetyana Shandala,Robert Saint,Peter J. Smith,Marie Dziadek	254
18	Cyclin A Expression in Normal and Transformed Alveolar Epithelial Cells 1993 ·American Journal of Respiratory Cell and Molecular Biology ·Kim Chi Bui,Frank Wu,(unknown),Lingtao Wu,Richard T. Williams,D. A. Carbonaro-Hall,Frederick L. Hall,David Warburton	18
19	An FKBP‐Rapamycin‐Sensitive, Cyclin‐Dependent Kinase Activity that Correlates with the FKBP‐Rapamycin‐Induced G1 Arrest Point in MG‐63 Cells^a 1993 ·Annals of the New York Academy of Sciences ·Mark W. Albers,Eric J. Brown,Akito Tanaka,Richard T. Williams,Frederick L. Hall,Stuart L. Schreiber	14
20	FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. 1993 ·Journal of Biological Chemistry ·Mark W. Albers,Richard T. Williams,Eric J. Brown,(unknown),Frederick L. Hall,S.L. Schreiber	128

About Richard T. Williams

Richard T. Williams is a scholar working on Hematology, Cancer Research and Oncology, having authored 60 papers that have together received 4.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (13 papers), Cancer Genomics and Diagnostics (9 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Sensory Systems (528 citations), Cancer Research (1.3k citations) and Oncology (1.7k citations). Richard T. Williams has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Charles J. Sherr, Kelly S. Oliner, Isaac Kinde, Johannes G. Reiter, Martin A. Nowak, Kenneth W. Kinzler, Luis A. Díaz, Benjamin Allen, Jian Wu and Ivana Božić. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact